Upregulation of lncRNA MEG3 promotes hepatic insulin resistance via increasing FoxO1 expression

Biochemical and Biophysical Research Communications

Volumn 469, Issue 2, 2016, Pages 319-325

  Zhu, Xiang ^a   Wu, Yuan Bo ^a   Zhou, Jian ^a   Kang, Dong Mei ^a  

^a ANHUI MEDICAL UNIVERSITY   (China)

Author keywords

FoxO1; Hepatic insulin resistance; lncRNA MEG3; Primary hepatocytes

Indexed keywords

G6PC PROTEIN; GLUCOSE; GLYCOGEN; HISTONE DEACETYLASE 1; HISTONE DEACETYLASE 3; LINOLEIC ACID; LONG UNTRANSLATED RNA; LONG UNTRANSLATED RNA MEG3; OLEIC ACID; PALMITIC ACID; PEPCK PROTEIN; PROTEIN; TRANSCRIPTION FACTOR FKHR; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; FORKHEAD TRANSCRIPTION FACTOR; FOXO1 PROTEIN, MOUSE; MEG3 NON-CODING RNA, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; DOWN REGULATION; GENE OVEREXPRESSION; GLUCONEOGENESIS; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE; GLUCOSE TOLERANCE TEST; GLYCOGEN LIVER LEVEL; GLYCOGEN SYNTHESIS; HEPATIC INSULIN RESISTANCE; HISTONE ACETYLATION; IMPAIRED GLUCOSE TOLERANCE; INSULIN RESISTANCE; INTRAPERITONEAL GLUCOSE TOLERANCE TEST; LIPID DIET; LIPID LIVER LEVEL; LIPID STORAGE; LIVER CELL; LOW FAT DIET; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; UPREGULATION; WESTERN BLOTTING; ANIMAL; C57BL MOUSE; LIVER; METABOLISM; OBESITY;

ANIMALS; FORKHEAD TRANSCRIPTION FACTORS; INSULIN RESISTANCE; LIVER; MALE; MICE; MICE, INBRED C57BL; OBESITY; RNA, LONG NONCODING; UP-REGULATION;

EID: 84951908383     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2015.11.048     Document Type: Article

References (34)

1. V.T. Samuel, and G.I. Shulman Mechanisms for insulin resistance: common threads and missing links Cell 148 2012 852 871
2. D.M. Muoio, and C.B. Newgard Mechanisms of disease:Molecular and metabolic mechanisms of insulin resistance and beta-cell failure in type 2 diabetes Nat. Rev. Mol. Cell Biol. 9 2008 193 205
3. A.J. Lusis, A.D. Attie, and K. Reue Metabolic syndrome: from epidemiology to systems biology Nat. Rev. Genet. 9 2008 819 830
4. Z. Wu, P. Jiao, X. Huang, B. Feng, Y. Feng, S. Yang, and et al. MAPK phosphatase-3 promotes hepatic gluconeogenesis through dephosphorylation of forkhead box O1 in mice J. Clin. Investig. 120 2010 3901 3911
5. P. Puigserver, J. Rhee, J. Donovan, C.J. Walkey, J.C. Yoon, F. Oriente, and et al. Insulin-regulated hepatic gluconeogenesis through FOXO1-PGC-1alpha interaction Nature 423 2003 550 555
6. D.N. Gross, A.P. van den Heuvel, and M.J. Birnbaum The role of FoxO in the regulation of metabolism Oncogene 27 2008 2320 2336
7. B.T. Bikman, and S.A. Summers Ceramides as modulators of cellular and whole-body metabolism J. Clin. Investig. 121 2011 4222 4230
8. M. Matsumoto, A. Pocai, L. Rossetti, R.A. Depinho, and D. Accili Impaired regulation of hepatic glucose production in mice lacking the forkhead transcription factor Foxo1 in liver Cell Metab. 6 2007 208 216
9. W. Huang, J. Yu, X. Jia, L. Xiong, N. Li, and X. Wen Zhenqing recipe improves glucose metabolism and insulin sensitivity by repressing hepatic FOXO1 in type 2 diabetic rats Am. J. Chin. Med. 40 2012 721 733
10. P.J. Batista, and H.Y. Chang Long noncoding RNAs: cellular address codes in development and disease Cell 152 2013 1298 1307
11. L. Yang, J.E. Froberg, and J.T. Lee Long noncoding RNAs: fresh perspectives into the RNA world Trends Biochem. Sci. 39 2014 35 43
12. Y. He, X.M. Meng, C. Huang, B.M. Wu, L. Zhang, X.W. Lv, and et al. Long noncoding RNAs: novel insights into hepatocelluar carcinoma Cancer Lett. 344 2014 20 27
13. J.L. Huang, L. Zheng, Y.W. Hu, and Q. Wang Characteristics of long non-coding RNA and its relation to hepatocellular carcinoma Carcinogenesis 35 2014 507 514
14. C. Braconi, T. Kogure, N. Valeri, N. Huang, G. Nuovo, S. Costinean, and et al. microRNA-29 can regulate expression of the long non-coding RNA gene MEG3 in hepatocellular cancer Oncogene 30 2011 4750 4756
15. E.M. Morris, G.M. Meers, F.W. Booth, K.L. Fritsche, C.D. Hardin, J.P. Thyfault, and et al. PGC-1alpha overexpression results in increased hepatic fatty acid oxidation with reduced triacylglycerol accumulation and secretion Am. J. Physiol. Gastrointest. Liver Physiol. 303 2012 G979 G992
16. T. Galbo, R.J. Perry, E. Nishimura, V.T. Samuel, B. Quistorff, and G.I. Shulman PP2A inhibition results in hepatic insulin resistance despite Akt2 activation Aging 5 2013 770 781
17. T. Galbo, G.S. Olsen, B. Quistorff, and E. Nishimura Free fatty acid-induced PP2A hyperactivity selectively impairs hepatic insulin action on glucose metabolism PloS One 6 2011 e27424
18. D. Accili Lilly lecture 2003: the struggle for mastery in insulin action: from triumvirate to republic Diabetes 53 2004 1633 1642
19. D.N. Gross, M. Wan, and M.J. Birnbaum The role of FOXO in the regulation of metabolism Curr. Diabet. Rep. 9 2009 208 214
20. A. Wajngot, V. Chandramouli, W.C. Schumann, K. Ekberg, P.K. Jones, S. Efendic, and et al. Quantitative contributions of gluconeogenesis to glucose production during fasting in type 2 diabetes mellitus Metab. Clin. Exp. 50 2001 47 52
21. A.A. Yarushkin, E.M. Kachaylo, and V.O. Pustylnyak The constitutive androstane receptor activator 4-[(4R,6R)-4,6-diphenyl-1,3-dioxan-2-yl]-N,N-dimethylaniline inhibits the gluconeogenic genes PEPCK and G6Pase through the suppression of HNF4alpha and FOXO1 transcriptional activity Br. J. Pharmacol. 168 2013 1923 1932
22. Y. Zhou, X. Zhang, and A. Klibanski MEG3 noncoding RNA: a tumor suppressor J. Mol. Endocrinol. 48 2012 R45 R53
23. S. Cairo, C. Armengol, A. De Reynies, Y. Wei, E. Thomas, C.A. Renard, and et al. Hepatic stem-like phenotype and interplay of Wnt/beta-catenin and Myc signaling in aggressive childhood liver cancer Cancer Cell 14 2008 471 484
24. E.W. Tobi, L.H. Lumey, R.P. Talens, D. Kremer, H. Putter, A.D. Stein, and et al. DNA methylation differences after exposure to prenatal famine are common and timing- and sex-specific Hum. Mol. Genet. 18 2009 4046 4053
25. R.A. Haeusler, K.H. Kaestner, and D. Accili FoxOs function synergistically to promote glucose production J. Biol. Chem. 285 2010 35245 35248
26. K. Zhang, L. Li, Y. Qi, X. Zhu, B. Gan, R.A. DePinho, and et al. Hepatic suppression of Foxo1 and Foxo3 causes hypoglycemia and hyperlipidemia in mice Endocrinology 153 2012 631 646
27. M. Matsumoto, S. Han, T. Kitamura, and D. Accili Dual role of transcription factor FoxO1 in controlling hepatic insulin sensitivity and lipid metabolism J. Clin. Investig. 116 2006 2464 2472
28. I. OS, W. Zhang, D.H. Wasserman, C.W. Liew, J. Liu, J. Paik, and et al. FoxO1 integrates direct and indirect effects of insulin on hepatic glucose production and glucose utilization Nat. Commun. 6 2015 7079
29. J.A. Hall, M. Tabata, J.T. Rodgers, and P. Puigserver USP7 attenuates hepatic gluconeogenesis through modulation of FoxO1 gene promoter occupancy Mol. Endocrinol. 28 2014 912 924
30. B. Feng, Q. He, and H. Xu FOXO1-dependent up-regulation of MAP kinase phosphatase 3 (MKP-3) mediates glucocorticoid-induced hepatic lipid accumulation in mice Mol. Cell. Endocrinol. 393 2014 46 55
31. Q. Wang, N. Wang, M. Dong, F. Chen, Z. Li, and Y. Chen GdCl3 reduces hyperglycaemia through Akt/FoxO1-induced suppression of hepatic gluconeogenesis in Type 2 diabetic mice Clin. Sci. 127 2014 91 100
32. U.B. Pajvani, C.J. Shawber, V.T. Samuel, A.L. Birkenfeld, G.I. Shulman, J. Kitajewski, and et al. Inhibition of Notch signaling ameliorates insulin resistance in a FoxO1-dependent manner Nat. Med. 17 2011 961 967
33. H. Liu, M.M. Fergusson, J.J. Wu, Rovira II, J. Liu, O. Gavrilova, and et al. Wnt signaling regulates hepatic metabolism Sci. Signal. 4 2011 ra6
34. M.P. Sajan, R.A. Ivey, M.C. Lee, and R.V. Farese Hepatic insulin resistance in ob/ob mice involves increases in ceramide, aPKC activity, and selective impairment of Akt-dependent FoxO1 phosphorylation J. Lipid Res. 56 2015 70 80